According to multiple websites that track grey market activities, Sai Life Sciences’s shares are commanding a premium of Rs 37. This translates into a GMP of 6.74 per cent

The Qualified Institutional Buyers (QIBs) booked their quota 2.88 times even as the investors in other categories adopted a cautious approach. The portion reserved for retail investors was booked 30% whereas the Non-Institutional Investors (NIIs) booked 28% of the shares set aside for them.

The unlisted shares of Sai Life Sciences were trading at Rs 586 apiece, reflecting a grey market premium (GMP) of Rs 37 or 6.74 per cent per share over the upper end of the IPO price band of Rs 549

Sai Life Sciences' IPO saw an 84% subscription rate on its first day. Institutional investors showed strong interest. The IPO aims to raise Rs 3,042 crore. The company plans to use the funds for debt repayment.

Sai Life Sciences Ltd.'s initial public offering entered the second day on Thursday. It was subscribed 0.89 times or 89% as of 11:06 a.m. The company aims to raise Rs 3,042 crore via the offering.

Sai Life Sciences IPO GMP price, allotment, Subscription details: The company raised a sum of Rs 912.79 crore from anchor investors by selling 1.66 crore shares.

Sai Life Sciences IPO opens for public subscription today, Wednesday, December 11, 2024, and will close on Friday, December 13, 2024

Bidding for Rs 3,042.62 crore IPO is all set to open on December 11, and its latest grey market premium (GMP) is already hinting at premium listing on BSE and NSE.

Shares of Sai Life Sciences were trading at a premium of ₹28 in the grey market, at 4:30 PM on December 11, as per reports. The latest GMP for Sai Life Sciences IPO indicates an expected listing price of ₹577 per share with a potential listing gain of 5%.

Sai Life Sciences IPO opened for for public subscription on Wednesday, December 11 and will close on Friday, December 13. The public issue has received healthy booking from the QIB segment on Day 1.